Novel HMG-CoA reductase inhibitors
AssigneeRorer Pharmaceutical Corporation
InventorsJohn R. Regan, Josehp G. Bruno, Kent W. Neuenschwander, Donald E. Kuhla
Life of this patent
Estimating the term…
Abstract
Disclosed are novel 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors useful as antihypercholesterolemic agents represented by the formula ##STR1## and the corresponding ring-opened hydroxy acids derived therefrom and pharmaceutically acceptable salts thereof. Pharmaceutical compositions containing said compounds and method of inhibiting the biosynthesis of cholesterol therewith are also disclosed.
Claims25
A compound of the formula ##STR4## and the pharmaceutically acceptable salts thereof wherein Y is:
- --CHR--,
- --CHRCHR--,
- --CHRCHRCHR--, or
- --RC.dbd.CR--;
- X, X.sub.1 and X.sub.2 are independently:
- H, F, Cl, Br, OH, CF.sub.3 alkyl, alkoxy, aryl, NO.sub.2, NH(CO)R, N(R).sub.2, or S(O).sub.n R;
- R, R.sub.1, R.sub.2, R.sub.3 and R.sub.4 are independently:
- H or lower alkyl;
- m is:
- 1 or 2;
- m' is:
- 0 or 1;
- m" is:
- 0 or 1;
- n=0, 1, 2;
- and
- the dotted lines in the bicyclic ring represent optional double bonds.
Trans-(E)-6-[2-[3-(4-fluorophenyl)bicyclo[3.2.1]oct-2-en-2 -yl]ethenyl]-3,4,5,6-tetrahydro-4-hydroxy-2H-pyran-2-one.
Trans-(E)-6-[2-[cis-exo-3-(4-fluorophenylmethyl)bicyc lo[2.2.2]oct-5-en-2-yl]ethenyl]-3,4,5,6-tetrahydro-4-hydroxy-2H-pyran-2-one .
Trans-(E)-6-[2-[3-(4-fluoro-3-methylphenyl)-1,5-dimethylbicyclo[3.2.1]o ct-2-en-2-yl]ethenyl]-3,4,5,6-tetrahydro-4-hydroxy-2H-pyran-2-one.
Trans-(E)-6-[2-[3-(4-fluoro-3-chlorophenyl)-1,5-di(1-methylethyl) bicyclo[3.2.1]oct-2-en-2-yl]ethenyl]-3,4,5,6-tetrahydro-4-hydroxy-2H-pyran -2-one.
Tra ns-6-[2-[cis-endo-3-(4-methylphenyl)bicyclo[3.2.1]-pctan=2-yl]ethyl]-3,4,5, 6-tetrahydro-4-hydroxy-2H-pyran-2-one.
Trans-(E)-6-[2-[3-(4-fluoro-3-meth ylphenyl)-1,5-dimethylbicyclo[3.2.1]octa-2,6-dien-2-yl]ethenyl]-3,4,5,6-tet rahydro-4-hydroxy-2H-pyran-2-one.
Trans-(E)-6-[2-[cis-exo-3-(4- fluoro-3-methylphenyl)bicyclo[2.2.2]oct-5-en-2-yl]ethenyl]-3,4,5,6-tetrahyd ro-4-hydroxy-2H-pyran-2-one.
Trans-(E)-6-[2-[3-(4-flu oro-3-methylphenyl)-1,4-dimethylbicyclo[2.2.2]octa-2,5-dien-2-yl]ethenyl]-3 ,4,5,6-tetrahydro-4-hydroxy-2H-pyran-2-one.
Trans-(E)-6-[2-[trans-3-(3,4-ditrifluorophenyl)-1,4-di(2-methylethyl) bicyclo-[2.2.2]octan-2-yl]ethyl]-3,4,5,6-tetrahydro-4-hydroxy-2H-pyran-2-o ne.
Trans-(E)-6-[3-(3-methylphenylmethyl)-1-methylbicyclo[2.2.2]oct-2-en-2-yl] ethenyl]-3,4,5,6-tetrahydro-4-hydroxy-2H-pyran-2-one.
Dependencies are inferred from the claim text.